Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06052137
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-13
First Post:
2023-09-18
Brief Title:
Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate the anti-anhedonic efficacy of a novel neurostimulation strategy termed accelerated intermittent theta burst stimulation aiTBS in participants with treatment resistant depression TRD
Detailed Description:
Repetitive transcranial magnetic stimulation rTMS is an established therapy for treatment-resistant depression The approved method for treatment is 10Hz stimulation for 40 min over the left dorsolateral prefrontal cortex L-DLPFC This methodology has been effective in real world situations The limitations of this approach include the duration of the treatment approximately 40 minutes per treatment session 5 days per week for 4-8 weeks Recently the investigators have pursued modifying the treatment parameters to reduce treatment times with an accelerated treatment paradigm This study aims to further study the accelerated protocol and examine changes in neuroimaging biomarkers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None